相似文献
1
Lighting up multiprotein complexes: lessons from GPCR oligomerization.
Trends Biotechnol. 2010 Aug;28(8):407-15. doi: 10.1016/j.tibtech.2010.05.002. Epub 2010 Jun 9.
2
Oligomerization of G protein-coupled receptors: biochemical and biophysical methods.
Curr Med Chem. 2011;18(30):4606-34. doi: 10.2174/092986711797379285.
3
Fluorescence resonance energy transfer-based technologies in the study of protein-protein interactions at the cell surface.
Methods. 2012 Aug;57(4):467-72. doi: 10.1016/j.ymeth.2012.05.007. Epub 2012 Jun 6.
4
Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art.
Int J Mol Sci. 2019 Jun 17;20(12):2958. doi: 10.3390/ijms20122958.
5
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization.
Methods Mol Biol. 2011;756:201-14. doi: 10.1007/978-1-61779-160-4_10.
6
A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.
Nat Methods. 2006 Dec;3(12):1001-6. doi: 10.1038/nmeth978. Epub 2006 Nov 5.
7
Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks.
Br J Pharmacol. 2010 Feb;159(4):738-50. doi: 10.1111/j.1476-5381.2009.00480.x. Epub 2009 Dec 10.
8
Combining SRET and BiFC to Study GPCR Heteromerization and Protein-Protein Interactions.
Methods Mol Biol. 2019;1947:199-215. doi: 10.1007/978-1-4939-9121-1_11.
9
Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors.
Biotechnol J. 2009 Sep;4(9):1337-44. doi: 10.1002/biot.200900016.
10
Application of BRET for studying G protein-coupled receptors.
Mini Rev Med Chem. 2014 May;14(5):411-25. doi: 10.2174/1389557514666140428113708.
引用本文的文献
1
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.
Front Endocrinol (Lausanne). 2022 Apr 19;13:880002. doi: 10.3389/fendo.2022.880002. eCollection 2022.
2
Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain.
Curr Neuropharmacol. 2022;20(6):1035-1045. doi: 10.2174/1570159X19666211104145727.
3
PTH hypersecretion triggered by a GABA and Ca-sensing receptor heterocomplex in hyperparathyroidism.
Nat Metab. 2020 Mar;2(3):243-255. doi: 10.1038/s42255-020-0175-z. Epub 2020 Mar 9.
4
The plakin domain of VAB-10/plectin acts as a hub in a mechanotransduction pathway to promote morphogenesis.
Development. 2019 Dec 13;146(24):dev183780. doi: 10.1242/dev.183780.
5
Design and development of stapled transmembrane peptides that disrupt the activity of G-protein-coupled receptor oligomers.
J Biol Chem. 2019 Nov 8;294(45):16587-16603. doi: 10.1074/jbc.RA119.009160. Epub 2019 Aug 29.
6
Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art.
Int J Mol Sci. 2019 Jun 17;20(12):2958. doi: 10.3390/ijms20122958.
7
Muscarinic receptor oligomerization.
Neuropharmacology. 2018 Jul 1;136(Pt C):401-410. doi: 10.1016/j.neuropharm.2017.11.023. Epub 2017 Nov 14.
8
Contributions of fluorescence techniques to understanding G protein-coupled receptor dimerisation.
Biophys Rev. 2012 Dec;4(4):291-298. doi: 10.1007/s12551-012-0073-z. Epub 2012 Apr 12.
9
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.
Front Endocrinol (Lausanne). 2017 Apr 24;8:86. doi: 10.3389/fendo.2017.00086. eCollection 2017.
10
Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.
PLoS One. 2016 Nov 3;11(11):e0165420. doi: 10.1371/journal.pone.0165420. eCollection 2016.
本文引用的文献
1
Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.
CNS Neurosci Ther. 2010 Jun;16(3):e18-42. doi: 10.1111/j.1755-5949.2009.00126.x. Epub 2010 Mar 16.
2
Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers.
J Pharmacol Exp Ther. 2010 Mar;332(3):710-9. doi: 10.1124/jpet.109.162701. Epub 2009 Dec 16.
3
Receptor-receptor interactions: A novel concept in brain integration.
Prog Neurobiol. 2010 Feb 9;90(2):157-75. doi: 10.1016/j.pneurobio.2009.10.004. Epub 2009 Oct 20.
4
N terminus of type 5 adenylyl cyclase scaffolds Gs heterotrimer.
Mol Pharmacol. 2009 Dec;76(6):1256-64. doi: 10.1124/mol.109.058370. Epub 2009 Sep 25.
5
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.
Nat Chem Biol. 2009 Oct;5(10):734-42. doi: 10.1038/nchembio.206. Epub 2009 Aug 23.
6
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells.
J Neurochem. 2009 Jun;109(5):1497-507. doi: 10.1111/j.1471-4159.2009.06078.x. Epub 2009 Mar 30.
7
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.
Br J Pharmacol. 2009 Sep;158(1):5-14. doi: 10.1111/j.1476-5381.2009.00169.x. Epub 2009 Mar 20.
8
Fluorescence lifetime and polarization-resolved imaging in cell biology.
Curr Opin Biotechnol. 2009 Feb;20(1):28-36. doi: 10.1016/j.copbio.2009.01.004. Epub 2009 Mar 4.
9
Analysis of receptor oligomerization by FRAP microscopy.
Nat Methods. 2009 Mar;6(3):225-30. doi: 10.1038/nmeth.1304. Epub 2009 Feb 22.
10
Heterodimers and receptor mosaics of different types of G-protein-coupled receptors.
Physiology (Bethesda). 2008 Dec;23:322-32. doi: 10.1152/physiol.00028.2008.
Zotero 插件